TY - JOUR
T1 - Allostatic load as predictor of mortality
T2 - a cohort study from Lolland-Falster, Denmark
AU - Bruun-Rasmussen, Neda Esmailzadeh
AU - Napolitano, George
AU - Christiansen, Christian
AU - Bojesen, Stig Egil
AU - Ellervik, Christina
AU - Jepsen, Randi
AU - Rasmussen, Knud
AU - Lynge, Elsebeth
N1 - © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2022/5/27
Y1 - 2022/5/27
N2 - OBJECTIVES: The purposes of the present study were to determine the association between (1) 10 individual biomarkers and all-cause mortality; and between (2) allostatic load (AL), across three physiological systems (cardiovascular, inflammatory, metabolic) and all-cause mortality.DESIGN: Prospective cohort study.SETTING: We used data from the Lolland-Falster Health Study undertaken in Denmark in 2016-2020 and used data on systolic blood pressure (SBP) and diastolic blood pressure (DBP), pulse rate (PR), waist-hip ratio (WHR) and levels of low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), triglycerides, glycated haemoglobin A1c (HbA1c), C-reactive protein (CRP) and serum albumin. All biomarkers were divided into quartiles with high-risk values defined as those in the highest (PR, WHR, triglycerides, HbA1c, CRP) or lowest (HDL-c, albumin) quartile, or a combination hereof (LDL-c, SBP, DBP). The 10 biomarkers were combined into a summary measure of AL index. Participants were followed-up for death for an average of 2.6 years.PARTICIPANTS: We examined a total of 13 725 individuals aged 18+ years.PRIMARY OUTCOME MEASURE: Cox proportional hazard regression (HR) analysis were performed to examine the association between AL index and mortality in men and women.RESULTS: All-cause mortality increased with increasing AL index. With low AL index as reference, the HR was 1.33 (95% CI: 0.89 to 1.98) for mid AL, and HR 2.37 (95% CI: 1.58 to 3.54) for high AL.CONCLUSIONS: Elevated physiological burden measured by mid and high AL index was associated with a steeper increase of mortality than individual biomarkers.
AB - OBJECTIVES: The purposes of the present study were to determine the association between (1) 10 individual biomarkers and all-cause mortality; and between (2) allostatic load (AL), across three physiological systems (cardiovascular, inflammatory, metabolic) and all-cause mortality.DESIGN: Prospective cohort study.SETTING: We used data from the Lolland-Falster Health Study undertaken in Denmark in 2016-2020 and used data on systolic blood pressure (SBP) and diastolic blood pressure (DBP), pulse rate (PR), waist-hip ratio (WHR) and levels of low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), triglycerides, glycated haemoglobin A1c (HbA1c), C-reactive protein (CRP) and serum albumin. All biomarkers were divided into quartiles with high-risk values defined as those in the highest (PR, WHR, triglycerides, HbA1c, CRP) or lowest (HDL-c, albumin) quartile, or a combination hereof (LDL-c, SBP, DBP). The 10 biomarkers were combined into a summary measure of AL index. Participants were followed-up for death for an average of 2.6 years.PARTICIPANTS: We examined a total of 13 725 individuals aged 18+ years.PRIMARY OUTCOME MEASURE: Cox proportional hazard regression (HR) analysis were performed to examine the association between AL index and mortality in men and women.RESULTS: All-cause mortality increased with increasing AL index. With low AL index as reference, the HR was 1.33 (95% CI: 0.89 to 1.98) for mid AL, and HR 2.37 (95% CI: 1.58 to 3.54) for high AL.CONCLUSIONS: Elevated physiological burden measured by mid and high AL index was associated with a steeper increase of mortality than individual biomarkers.
KW - Allostasis/physiology
KW - Biomarkers
KW - C-Reactive Protein/analysis
KW - Cholesterol, HDL
KW - Cholesterol, LDL
KW - Cohort Studies
KW - Denmark/epidemiology
KW - Female
KW - Glycated Hemoglobin/analysis
KW - Humans
KW - Male
KW - Prospective Studies
KW - Triglycerides
UR - http://www.scopus.com/inward/record.url?scp=85131108797&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2021-057136
DO - 10.1136/bmjopen-2021-057136
M3 - Journal article
C2 - 35623757
SN - 2399-9772
VL - 12
SP - e057136
JO - BMJ Paediatrics Open
JF - BMJ Paediatrics Open
IS - 5
M1 - e057136
ER -